Vienna
Austria
42
2022-03-10
28
2024-08-20
These are the the leading inventors for applications assigned to Affiris AG:
Affiris AG based in Vienna, AT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Substances and methods for the use in prevention and/or treatment in huntingon's disease
#2 | 2021-02-11SUBSTANCES AND METHODS FOR THE USE IN PREVENTION AND/OR TREATMENT IN HUNTINGTON'S DISEASE
#3 | 2020-10-29 β Patent 11,147,873 granted on 2021-10-19Treatment of Alzheimer's Disease (AD) with an aluminum salt
#4 | 2020-08-13 β Patent 11,534,484 granted on 2022-12-27Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy
#5 | 2020-01-16IL-23-P19 VACCINES
#6 | 2019-05-02ALPHA CHAIN OF THE HIGH-AFFINITY IGE RECEPTOR (FCERIA)
#7 | 2019-03-28 β Patent 12,290,553 granted on 2025-05-06Method for vaccination against a self-antigen in a human patient
#8 | 2018-11-15SUBSTANCES AND METHODS FOR THE USE IN PREVENTION AND/OR TREATMENT IN HUNTINGTON'S DISEASE
#9 | 2018-10-11 β Patent 10,933,123 granted on 2021-03-02Peptide vaccines usable for hypercholesterolemia related diseases
#10 | 2018-07-05VACCINES FOR THE TREATMENT AND PREVENTION OF IGE MEDIATED DISEASES
#11 | 2018-04-26 β Patent 10,576,131 granted on 2020-03-03IL-23-p19 vaccines
#12 | 2017-10-26 β Patent 10,406,197 granted on 2019-09-10Substances and methods for the use in prevention and/or treatment in Huntington's disease
#13 | 2017-06-08 β Patent 10,517,935 granted on 2019-12-31Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
#14 | 2017-05-25 β Patent 10,053,518 granted on 2018-08-21Substances and methods for the use in prevention and/or treatment in Huntington's disease
#15 | 2017-05-18VACCINES AND MONOCLONAL ANTIBODIES TARGETING TRUNCATED VARIANTS OF OSTEOPONTIN AND USES THEREOF
#16 | 2017-04-27 β Patent 9,999,659 granted on 2018-06-19Treatments using a peptide and/or vaccine
#17 | 2017-03-09 β Patent 10,004,791 granted on 2018-06-26Peptide vaccines against PCSK9
#18 | 2017-03-02 β Patent 10,646,565 granted on 2020-05-12Treatment of alzheimer'S disease (AD) with an aluminum salt
#19 | 2017-02-23 β Patent 10,478,454 granted on 2019-11-19Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxide
#20 | 2017-02-23 β Patent 11,065,273 granted on 2021-07-20Treatment and prevention of alzheimer's disease (AD)
#21 | 2016-04-21 β Patent 9,669,079 granted on 2017-06-06PCSK9 peptide combination vaccine and method of use
#22 | 2016-02-25 β Patent 9,964,547 granted on 2018-05-08Method for detecting aSyn-specific antibodies in a biological sample
#23 | 2016-01-14METHOD FOR TREATING A beta-AMYLOIDOSIS
#24 | 2015-10-29METHOD FOR TREATING A SYNUCLEIOPATHY
#25 | 2015-10-29 β Patent 9,533,030 granted on 2017-01-03Vaccine capable of inducing formation of antibodies directed to proprotein convertase subtilisin/kexin type 9 (PCSK9) in vivo
#26 | 2015-06-18 β Patent 10,344,062 granted on 2019-07-09Method of inhibiting C5a
#27 | 2015-04-02COMPOSITION
#28 | 2015-04-02COMPOSITIONS
#29 | 2015-03-12 β Patent 9,220,762 granted on 2015-12-29PCSK9 peptide combination vaccine and method of use
#30 | 2014-09-11Vaccine
#31 | 2014-08-28 β Patent 9,625,459 granted on 2017-04-18Method for diagnosing alzheimer's disease (AD)
#32 | 2014-08-21METHOD FOR DETECTING A BETA-SPECIFIC ANTIBODIES IN A BIOLOGICAL SAMPLE
#33 | 2014-06-26TREATMENT OF ATHEROSCLEROSIS WITH CHOLESTEROL ESTER TRANSPORT PROTEIN MIMOTOPES
#34 | 2014-05-29 β Patent 9,085,636 granted on 2015-07-21CETP fragments
#35 | 2013-08-22 β Patent 9,457,078 granted on 2016-10-04Methods for inhibiting C5a with C5a peptides coupled or fused to a carrier protein
#36 | 2012-10-25 β Patent 9,029,327 granted on 2015-05-12Vaccine
#37 | 2012-06-21 β Patent 8,828,942 granted on 2014-09-09Means for treating synucleinopathies
#38 | 2011-11-10 β Patent 8,618,046 granted on 2013-12-31Treatment of atherosclerosis with cholesterol ester transport protein mimotopes
#39 | 2011-07-14 β Patent 8,409,581 granted on 2013-04-02Compounds for treating amyloidoses
#40 | 2011-04-28 β Patent 8,613,931 granted on 2013-12-24Compounds for treating beta-amyloidoses
#41 | 2011-04-21COMPOUNDS FOR TREATING SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE
#42 | 2011-04-21 β Patent 9,724,399 granted on 2017-08-08Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
Also check out AFFIRIS AG's (Vienna, Austria) applicant profile with 15 patent applications submitted.
35855 β